In the last trading session, 1.12 million shares of the Cue Biopharma Inc (NASDAQ:CUE) were traded, and its beta was 1.70. Most recently the company’s
Cue Biopharma Inc (NASDAQ:CUE)’s traded shares stood at 1.21 million during the last session, with the company’s beta value hitting 1.73. At the close of
Cue Biopharma Inc (NASDAQ:CUE)’s traded shares stood at 1.33 million during the last session, with the company’s beta value hitting 1.72.The CUE share’s 52-week high
In last trading session, Cue Biopharma Inc (NASDAQ:CUE) saw 0.55 million shares changing hands with its beta currently measuring 1.76. Company’s recent per share price
During the last session, Cue Biopharma Inc (NASDAQ:CUE)’s traded shares were 0.58 million, with the beta value of the company hitting 1.80. At the end
In the latest trading session, 1.79 million Cue Biopharma Inc (NASDAQ:CUE) shares changed hands as the company’s beta touched 1.98. With the company’s most recent
During the last session, Cue Biopharma Inc (NASDAQ:CUE)’s traded shares were 0.46 million, with the beta value of the company hitting 1.91. At the end
During the last session, Cue Biopharma Inc (NASDAQ:CUE)’s traded shares were 1.05 million, with the beta value of the company hitting 1.93. At the end
In the last trading session, 2.32 million shares of the Cue Biopharma Inc (NASDAQ:CUE) were traded, and its beta was 1.91. Most recently the company’s
In the last trading session, 6.01 million shares of the Cue Biopharma Inc (NASDAQ:CUE) were traded, and its beta was 1.94. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
